一种奇诺隆N-氧化物抗生素通过其毒素-抗毒素系统选择性地向尼塞利亚淋病
Ann-Kathrin Mix1, Thi Hong Nhung Nguyen2, Tamara Schuhmacher1
1Lehrstuhl Zellbiologie, Department of Biology, University of Konstanz, Konstanz, Germany.
Nature microbiology
|April 2, 2025
概括
一种新型化合物,2-nonyl-4-quinolone N-oxide (NQNO),通过破坏细菌的能量产生和激活毒素,有效地抑制了多药耐药性淋病. 修改后的版本显示出强烈的活性,并预防小鼠感染.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 淋病是一种性传播感染,是全球重要的健康问题.
- 耐多药性淋病菌株Neisseria gonorrhoeae的兴起需要开发新的治疗策略.
研究的目的:
- 为了确定新型抗微生物药物有效对抗尼塞里亚淋病菌.
- 研究Pseudomonas aeruginosa衍生二次代谢物的作用机制和治疗潜力.
主要方法:
- 对Pseudomonas aeruginosa二次代谢物的查,以检测它们对尼塞利亚淋病的活性.
- 在体外测试2-nonyl-4-quinolone N-oxide (NQNO) 的疗效和选择性.
- 涉及电子运输链中断,ATP/NADH耗尽和氧化应激诱导的机制研究.
- 在淋病感染的小鼠模型中评估NQNO及其衍生物3-甲基NQNO.
主要成果:
- 在实验室中,NQNO显示出强大的内性淋病菌增长抑制作用,而不会影响共生细菌或人体细胞.
- NQNO破坏了细菌的电子运输链,导致能量耗尽和氧化应激增加.
- 这种机制触发了内源性Zeta1毒素的释放,导致细菌死亡.
- 3-甲基NQNO表现出对多抗菌株的纳米分子功效,防止了耐药性发展,并在体内显著降低了细菌负载.
结论:
- NQNO代表了治疗淋病的有希望的候选人,特别是多药耐药菌株.
- 通过激活内源毒素选择性杀死病原体,提供了一种新的治疗方法.
- 进一步开发NQNO衍生物可能会导致对抗性细菌感染的有效治疗方法.
相关概念视频
01:26Anticholinesterase Agents: Poisoning and Treatment
761
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
761
01:27Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
632
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
632
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
495
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
495
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
00:57Antibiotic Selection
52.0K
Overview
52.0K